Memphis Pharmaceuticals & Chemical Industries (EGX: MPCI)
Egypt flag Egypt · Delayed Price · Currency is EGP
59.53
+9.92 (20.00%)
At close: Oct 14, 2024

MPCI Company Description

Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally.

The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones.

It also provides animal health products in powder form, as well as in oral and injectable solution forms.

The company was founded in 1940 and is based in Cairo, Egypt. Memphis Pharmaceuticals & Chemical Industries is a subsidiary of HoldiPharma.

Memphis Pharmaceuticals & Chemical Industries
Country Egypt
Founded 1940
Industry Pharmaceutical Preparations
Employees 144
CEO Bassem Abdullah

Contact Details

Address:
8 El Sawah - Amireya
Cairo, 11281
Egypt
Phone 20 2 2282 9880
Website memphis.com.eg

Stock Details

Ticker Symbol MPCI
Exchange Egyptian Stock Exchange
Fiscal Year July - June
Reporting Currency EGP
SIC Code 2834

Key Executives

Name Position
Bassem Abdullah Chief Executive Officer
Walid Hassan Chief Financial Officer